Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Phenyl-1,2,4-triazolidine-3,5-dione is a molecule that can be used for biological purposes. It has the chemical formula of C6H4N2O3 and a molecular weight of 180.14 g/mol. The hydrogen bonds between the hydroxyl group and the skeleton are strong enough to keep the molecule in shape. The molecule is thermally developable; it can be developed after exposure to heat or light. 1-Phenyl-1,2,4-triazolidine-3,5-dione has been shown to react with silver ions and metal surfaces such as aluminum and titanium oxide. This compound may also be useful for coatings that are reactive to light or heat because it will form a film when exposed to either one.</p>

<p>Versatile small molecule scaffold</p>

<p>1-Benzothiophene-6-carboxaldehyde (BTA) is a heterocyclic compound that contains sulfur. It is a colorless liquid with a sweet odor. BTA is used in the manufacture of pesticides, pharmaceuticals, and other organic chemicals. It is also used as a building block in the synthesis of other compounds and has been shown to have anti-inflammatory properties.</p>

<p>2-Hydroxy-4,6-dimethylbenzoic acid (HMBA) is a tumor treatment drug that can be used in combination with other drugs. HMBA inhibits proton pumps and the synthesis of DNA, RNA, and protein. The proton pump inhibitors are used to treat acid reflux disease, ulcers, and gastroesophageal reflux disease. HMBA has been shown to significantly inhibit tumor growth in animal studies. This drug also has anti-inflammatory effects and may be useful for treating arthritis.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Hydroxy-4-(phenylmethoxy)benzoic Acid Methyl Ester is a benzene derivative that inhibits the binding of xanthones to the benzene ring in a variety of ways. This compound is formed by reacting phenol with methyl benzoate in the presence of acid and heat. The low energy ligand inhibits the binding of xanthones to benzene by forming hydrogen bonds, covalent bonds, or van der Waals forces with the anion. 2-Hydroxy-4-(phenylmethoxy)benzoic acid methyl ester has shown anti-inflammatory properties, which may be due to its ability to inhibit leukocyte adhesion at inflammatory sites.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>tert-Butyl 2-cyclopentylidenehydrazinecarboxylate is a molecule that has been modified to be an agonist for the human liver. It has a profile of pharmacokinetic and molecular target similar to that of endogenous tyrosine kinase ligands, which are peptides and proteins involved in the regulation of metabolism, growth, and development. The pharmacokinetic profile of tert-Butyl 2-cyclopentylidenehydrazinecarboxylate can be optimized through structural modifications such as changes in hydrophobicity or lipophilicity. This optimization can increase its potency as a receptor agonist and lead to better treatment options for diseases such as type II diabetes.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1,3-Diphenylpropan-2-amine is a molecule with a hydrophobic nature. It has been shown to activate the enzyme monoamine oxidase in the brain, leading to an increase in the production of heat and causing hyperthermia. 1,3-Diphenylpropan-2-amine is metabolized by isozymes in different tissues and organs. 1,3-Diphenylpropan-2-amine interacts with pethidine (meperidine) to produce meperidine analogues, which are active at opioid receptors. These meperidine analogues have been shown to cause respiratory depression and hypotension when administered intravenously. The benzyl groups on this molecule have also been shown to interact with imidazoles such as ketoconazole and clotrimazole.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>